KEDI Palantir Fixed Tech100 Index

Honeywell Aerospace spin-off is scheduled to be completed on June 29, 2026, marking the final step in the company's portfolio transformation. The new company will trade under the ticker 'HONA'. This event is scheduled.

First quarter fiscal year 2027 earnings release on 2026-06-09 scheduled, with analyst EPS and revenue estimates forecasted. Importance is Medium as earnings releases are significant catalysts with ≥5% expected impact.

Datadog's annual conference, DASH, is scheduled to take place in New York City on June 9-10, 2026. Low impact is estimated as conference announcements typically have minimal market effect, scheduled.

A quarterly dividend of $1.19 per share is scheduled to be paid on June 5, 2026, to shareholders of record as of May 17, 2026. This event is scheduled.

Ex-dividend date for a quarterly dividend of $1.60 per share on June 4, 2026, following a 7% increase announced on April 27, 2026; a low impact is estimated as dividends typically result in minor price adjustments, scheduled.

Q1 2027 earnings release scheduled. Medium importance estimated as earnings releases typically drive significant volatility. Analysts forecast EPS around $1.18 forecasted.

Analysts estimate the Q4 Fiscal Year 2026 earnings release to occur on 2026-06-01; medium importance is estimated based on typical market volatility during earnings periods estimated.

Synopsys is scheduled to report its Q2 fiscal year 2026 financial results after market close on May 27, 2026, scheduled; scheduled dates typically have minimal immediate impact.

FDA PDUFA target action date for LEQEMBI's subcutaneous autoinjector formulation (IQLIK SC-AI) for initiation dosing, a potential new administration option for the Alzheimer's disease treatment, scheduled for 2026-05-24. High impact expected due to the significant market potential of the Alzheimer's treatment.

Workday is expected to announce its fiscal Q1 2027 earnings results on or around May 21, 2026. This is a recurring event with the potential for significant price impact based on results and guidance expected.

NVIDIA is scheduled to announce its financial results for the first quarter of fiscal year 2027, which ended on April 26, 2026, after market close on May 20, 2026. High importance is estimated as earnings reports typically trigger significant price movement, scheduled.

Analog Devices' Q2 2026 earnings release scheduled. Market reaction will depend on results versus expectations, scheduled.

Fiscal Q3 2026 earnings release on May 19, 2026 scheduled. Medium importance estimated based on historical price movement after earnings announcements.

Baidu is scheduled to report its financial results for the first quarter of 2026 on May 18, 2026, before the U.S. market opens. This is estimated to have a Low impact as the announcement of a reporting date typically results in minimal price movement scheduled.

Fiscal Q2 2026 earnings results are scheduled to be released on 2026-05-14. High importance is estimated as earnings results typically drive significant price volatility, with analysts forecasting EPS of approximately $2.66 forecasted.

Cisco's Q3 2026 earnings release and conference call are scheduled for May 13, 2026, scheduled.

Coinbase is scheduled to release its first quarter 2026 financial results after market close on May 7, 2026. This is a recurring event with high potential for price impact based on results versus analyst expectations, which are for lower revenue and EPS year-over-year. scheduled

Q1 2026 earnings release is scheduled for 2026-05-07. This event is estimated to have a high price impact as quarterly results often drive significant market volatility scheduled.

Microchip's Q4 and full fiscal year 2026 financial results conference call is scheduled for May 7, 2026. Analysts forecast revenue of approximately $1.26 billion and an adjusted EPS of $0.50. The market has priced in a potential post-earnings price move of over 11%, justifying the high importance scheduled.

Q1 2026 financial results and conference call scheduled for 2026-05-07. Analysts forecast revenue of ~$189 million and an EPS loss of ~$0.08, forecasted, scheduled. High importance estimated due to historical earnings-related price volatility exceeding 10%.

Q1 2026 earnings release is scheduled. Earnings announcements typically result in >5% price impact, scheduled.

Datadog is scheduled to report its first quarter fiscal year 2026 financial results on May 7, 2026. Low impact is estimated as the announcement of the reporting date itself typically has minimal market effect, scheduled.

AppLovin is scheduled to announce its Q1 2026 financial results after the market closes on May 6, 2026. This is a highly anticipated report, with market focus on the growth of its e-commerce advertising business. High importance is estimated due to the potential for significant price movement based on results and guidance, scheduled.

Axon is scheduled to report its first quarter 2026 financial results after the market closes on May 6, 2026, as announced by the company. This is a future event, so market impact is an estimate; earnings reports frequently cause significant price movement. scheduled

Fortinet is scheduled to announce its Q1 2026 financial results on May 6, 2026; analysts forecast EPS of $0.62 and revenue of $1.73 billion. This is rated medium as earnings are key volatility drivers forecasted and scheduled.

AMD fiscal Q1 2026 earnings results are scheduled to be released after market close on May 5, 2026; high impact expected as earnings typically drive >10% price volatility, scheduled.

Shopify is scheduled to announce its financial results for the first quarter of 2026 before markets open. High importance is estimated due to the potential for significant price movement typical of earnings releases, scheduled.

Palantir is scheduled to release its Q1 2026 financial results after the market closes on May 4, 2026. Market impact is estimated at >=5% as earnings releases are primary volatility drivers, scheduled.

Vertex Pharmaceuticals is scheduled to announce its first-quarter 2026 financial results after the market closes on May 4, 2026. This earnings release is estimated to have a >=5% price impact, scheduled

Linde is scheduled to release its first-quarter 2026 financial results on May 1, 2026. Analysts forecast EPS of approximately $4.27, an 8.1% year-over-year increase; a medium impact is estimated based on the growth rate, forecasted.

Effective May 1, 2026, Baidu implemented an organizational restructuring, unifying its professional and management job tracks into a single numerical grade system (Levels 5-12). This is estimated to have a Low impact as internal HR changes rarely cause immediate large-scale market movements expected.

Apple's fiscal Q2 2026 earnings results and investor conference call are scheduled for April 30, 2026. Analysts forecast revenue around $109-112 billion forecasted. High importance is estimated due to potential >10% price impact scheduled.

Amgen is scheduled to report its first quarter 2026 financial results after the market close on April 30, 2026, followed by a conference call with management, scheduled. High importance is estimated due to typical volatility surrounding earnings releases.

First quarter 2026 financial results are scheduled to be reported after the market close on April 30, 2026. Analysts forecast strong results driven by demand in the AI sector. High importance is estimated as earnings releases for this sector often result in ≥10% price impact. This is scheduled

Alnylam is scheduled to report its Q1 2026 financial results before the market opens on April 30, 2026. Analysts forecast EPS of $1.50 and revenue of approximately $1.13 billion. A neutral impact is expected as the market usually anticipates these figures, scheduled.

The U.S. Department of Commerce halted shipments of certain semiconductor manufacturing tools to China's Hua Hong on 2026-04-29, introducing regulatory risk and potential negative impact on revenue. High importance is estimated due to the significant revenue contribution from the affected customer.

Amazon reported Q1 2026 net sales of $181.5B (up 17% YoY) and EPS of $2.78, beating analyst expectations. The results included a $16.8B pre-tax gain from its investment in Anthropic. AWS revenue grew 28% YoY. The company provided positive guidance for Q2 2026.

The U.S. FDA accepted for Priority Review the New Drug Application (NDA) for the investigational once-daily single-tablet HIV treatment regimen, bictegravir/lenacapavir (BIC/LEN) on 2026-04-29. This major regulatory milestone is estimated to have a high price impact of over 10% due to the significance of the HIV franchise.

Alphabet reported Q1 2026 revenue of $109.9 billion and EPS of $5.11, significantly beating analyst estimates of $107 billion and $2.67, respectively. High importance is estimated due to the massive EPS beat which is expected to drive a >10% price impact, expected.

Regeneron reported Q1 2026 financial results, with revenue of $3.6 billion (a 19% YoY increase) and non-GAAP EPS of $9.47, beating analyst estimates. However, total Eylea franchise sales declined 10% and a temporary manufacturing interruption in Ireland impacted GAAP gross margin.

Reported Q3 2026 adjusted EPS of $3.37 and revenue of $5.94 billion, beating analyst expectations, and raised full-year fiscal 2026 guidance.

On April 29, 2026, reports emerged that Chinese authorities halted new robotaxi licenses after more than 100 Baidu Apollo Go vehicles stalled in Wuhan in March 2026. This is estimated to have a Medium impact as regulatory setbacks in key growth areas can significantly affect investor sentiment expected.

Reported Q1 2026 revenue of $2.48 billion (+2% YoY) and non-GAAP EPS of $3.57 (+18% YoY) on 2026-04-29, beating analyst expectations. The stock rose approximately 4.6% on the news.

Lowered full-year 2026 non-GAAP diluted EPS guidance to $14.25-$15.25 on 2026-04-29, from a prior range of $15.25-$16.25, to reflect charges related to business development activities.

Reported Q1 2026 results with revenue of $2.444 billion and adjusted FFO of $10.79 per share, missing analyst estimates. However, the company raised its full-year 2026 guidance for revenue, adjusted EBITDA, and AFFO, citing strong AI demand and record bookings.

KLA released fiscal 2026 third-quarter results on 2026-04-29, reporting revenue of $3.415 billion and non-GAAP EPS of $9.40, with fourth-quarter revenue guidance above consensus, but the stock fell more than 7% in extended trading.

Reported Q1 2026 financial results on 2026-04-29, beating revenue and adjusted EPS estimates. However, the company raised its full-year capital expenditure guidance to $125-$145 billion, causing the stock to decline over 6% in after-hours trading.

Microsoft announced fiscal Q3 2026 results on April 29, 2026, with revenue of $82.9 billion and EPS of $4.27, beating analyst estimates. Azure revenue grew 40%. A 5% or greater price impact is estimated based on the significant earnings beat, expected.

Shopify and live-shopping platform Whatnot launched a direct integration, allowing merchants to automatically sync products, inventory, and orders between the two platforms. Medium importance is estimated as this integration expands Shopify's ecosystem.

Xfinity Mobile, a Comcast brand, launched two new wireless plans, 'Mobile Plus' and 'Mobile Select', to attract and retain customers in its growing mobile segment. Low importance is estimated based on typical market response to product launches.

The Board of Directors declared a quarterly cash dividend of $5.16 per share, payable on June 17, 2026, to shareholders of record on May 20, 2026.

Reported Q2 2026 revenue of $10.6B (down 3% YoY) and non-GAAP EPS of $2.65, beating estimates. Issued Q3 revenue guidance of $9.2B-$10.0B and EPS of $2.10-$2.30, below consensus due to memory supply constraints. Stock fell ~4.5% in after-hours trading.

Shareholders approved the appointment of Belén Garijo as the new CEO, effective May 1, 2026, at the Annual General Meeting on April 29, 2026. (Low importance estimated as CEO transitions typically result in <5% price movement) scheduled.

On April 28, 2026, the U.S. FDA's CDER proposed to withdraw the approval for Amgen's drug Tavneos due to effectiveness and safety concerns. High importance is estimated as drug withdrawals significantly impact revenue and reputation.

NXP reported Q1 2026 revenue of $3.18 billion (+12% YoY) and non-GAAP EPS of $3.05, beating analyst estimates. The company also issued strong Q2 2026 guidance, forecasting revenue of $3.35-$3.55 billion, exceeding market expectations. This significant earnings beat and positive guidance are estimated to result in a price impact of 10% or more; expected.

Reported Q1 2026 revenue of $1.282 billion and non-GAAP EPS of $2.56 on 2026-04-28, beating analyst estimates. Despite the strong results driven by AI-related demand, the company's stock fell over 10% in subsequent trading, reportedly due to concerns over future growth and valuation.

AMD announced its 'Advancing AI 2026' event on April 28, 2026, scheduled for July 23, 2026; medium impact expected as major event announcements typically influence price by ~5%.

Booking Holdings reported Q1 2026 revenue of $5.5 billion (+16% YoY) and Adj. EPS of $1.14 on April 28, 2026, beating estimates. However, the company lowered its full-year 2026 guidance, citing negative impacts on travel demand from the conflict in the Middle East, causing the stock to drop over 6%.

On April 28, 2026, the FDA announced Amgen's participation in a new proof-of-concept pilot for real-time clinical trials (RTCT) for Imdelltra. Low importance is estimated as this is a procedural pilot program.

News reports on April 28, 2026 highlighted that company insiders sold approximately $339 million worth of stock over the prior three months, with no corresponding insider buying reported. Low importance is estimated as insider selling of this scale typically results in at least a 1% price impact, which is estimated

A South Korean court ruled in favor of Netflix on April 28, 2026, cancelling approximately KRW 68.7 billion in corporate taxes that had been imposed by the national tax authority. This is estimated to have a low market impact as the tax amount is small relative to the company's overall valuation.

Reported Q1 2026 revenue of $1.474 billion and non-GAAP EPS of $1.96, both beating analyst expectations. Raised full-year 2026 revenue guidance to $6.125-$6.225 billion, representing approximately 17% year-over-year growth. Medium importance estimated due to significant guidance raise.

Northland Capital Markets downgraded AMD stock to Market Perform on April 27, 2026; low impact expected as single analyst actions typically cause 1-3% price movement.

Mizuho analysts upgraded CRWD stock to 'Outperform' from 'Neutral' and raised the price target to $520 on 2026-04-27. Importance is Low as analyst upgrades typically result in ≥1% price impact.

Microsoft and OpenAI announced amended partnership terms on April 27, 2026, granting OpenAI more flexibility and making Microsoft's IP license non-exclusive. A 1% or greater price impact is estimated due to the structural partnership adjustment, expected.

Announced plans on 2026-04-24 to reduce its workforce by approximately 10%, or 8,000 jobs, to enhance efficiency and reallocate resources towards investments in artificial intelligence. This is estimated to have a medium impact (≥5%) due to the significant scale of restructuring.

The European Medicines Agency's CHMP recommended approval for tolebrutinib for multiple sclerosis on April 24, 2026. (Medium importance estimated as regulatory recommendations for key pipeline drugs often impact price by 5-10%) expected.

Alphabet announced its annual meeting for June 5, 2026, and filed proxy materials on April 24, 2026, including a proposal to add 200 million Class C shares to its 2021 Stock Plan. Low importance is estimated as this is a routine filing with expected <5% price impact, expected.

Shopify was announced as a founding member of the Universal Commerce Protocol (UCP) Tech Council, alongside Google, and joined by Amazon and Meta, to create open standards for AI-driven commerce. Low importance is estimated as this is a long-term industry initiative.

Intel reported Q1 2026 revenue of $13.6 billion and non-GAAP EPS of $0.29, significantly beating analyst forecasts. The strong results were driven by high demand for CPUs related to AI workloads. High importance is estimated due to the significant earnings beat expected.

On April 23, 2026, the FDA granted accelerated approval for Otarmeni, the first gene therapy for genetic hearing loss. Regeneron will provide the therapy for free in the U.S. and received a valuable Priority Review Voucher.

Comcast reported Q1 2026 earnings, with revenue of $31.5 billion and adjusted EPS of $0.79, beating analyst estimates. However, net income and adjusted EBITDA declined year-over-year, and the company lost 65,000 broadband subscribers. Medium importance is estimated based on typical market response to earnings reports.

Reported Q1 2026 adjusted EPS of $2.45, beating estimates, but revenue of $9.14 billion missed expectations. The company reaffirmed its full-year 2026 outlook but lowered GAAP EPS guidance, citing impacts from geopolitical conflict. The stock declined over 5% following the report.

Announced a €74 million investment to expand its Irish operations by 2027, including the creation of approximately 200 new roles focused on engineering and AI.

On or around April 23, 2026, Netflix's board of directors approved a new $25 billion share buyback program, signaling management's confidence in the company's value. This is estimated to have a medium market impact due to the significant scale of the program.

Successfully completed the 'Kakushin Rising' mission on 2026-04-23, deploying eight satellites for JAXA. Medium importance estimated as successful mission completions typically impact share price by 5-10%.

Sanofi reported Q1 2026 adjusted EPS of $1.10 and revenue of $12.3 billion on April 23, 2026, exceeding analyst expectations. (Medium importance estimated as earnings beats typically drive 5-10% price adjustments) expected.

Announced an agreement to sell its Warehouse and Workflow Solutions (WWS) business to American Industrial Partners as part of its portfolio simplification strategy. The transaction is expected to close in the second half of 2026.